Analgesia and Anesthesia for the Ill or Injured Dog and Cat provides a comprehensive guide to anesthesia and pain management protocols, specifically tailored to ill or critically injured dogs and cats.-Provides fast access to anesthesia and pain management protocols specifically tailored to ill or critically injured dogs and cats -Takes a case-based structure to make it easy to find and apply relevant information -Presents step-by-step clinical procedures and techniques -Supplies concise, relevant background information for all drugs recommended in the protocols, highlighting recommendations and cautions for specific patient conditions -Includes detailed information for geriatric, pregnant, nursing, and pediatric patients and those with cardiac, liver or kidney pathology.

Intro; Title Page; Copyright Page; Contents; List of Contributors; Preface; Acknowledgements; Chapter 1 General Considerations for Pain Management upon Initial Presentation and during Hospital Stay; References; Further Reading; Chapter 2 Physiology and Pathophysiology of Pain; I. Pain versus Nociception; II. The Pain Pathway in Physiologic Pain; A. Transduction; B. Transmission; C. Modulation; D. Perception; E. Endogenous Analgesic Pathways; III. The Pain Pathway in Pathologic Pain; A. Transduction; B. Transmission; C. Modulation; D. Perception; E. Descending Inhibitory Pathway. IV. Specific Types of PainA. Neonatal/Pediatric Pain; B. Neuropathic Pain; C. Visceral Pain; D. Breakthrough Pain; E. Stimulus-Evoked/Movement-Evoked Pain; References; Further Reading; Chapter 3 Physiologic and Pharmacologic Applications to Manage Neuropathic Pain; I. Physiology of Neuropathic Pain; A. The Patient's Experience; B. The Quality and Pattern of Altered Sensitivity; C. Immune Response Mechanisms in Neuropathic Pain; D. Endogenous Descending Facilitatory Systems [8]; E. Descending Inhibitory Pathway [9]; F. To Summarize Neuropathic Pain. II. Clinical Relevance of Physiology to PharmacologyA. Opioids/Opiates; B. Tricyclic Antidepressant Analgesic (TCA) Effects; C. Gabapentin; D. NMDA Receptor Antagonists; E. Local Anesthetics; F. Alpha2 Adrenergic (Alpha2) Agonists; G. Nonsteroidal Anti-Inflammatory Analgesics (NSAIAs); H. Acupuncture; III. Diagnosing Neuropathic Pain; IV. Neuropathic Pain Associated Conditions; A. Neuropathic Pain Associated with Trauma: Accidental and Surgical; B. Lumbosacral Lesions; C. Spinal Cord Injury; D. Potential Sources of Neck and Back Pain in Cats and Dogs. v. Primary Lesions of the Peripheral or central Nervous SystemA. Peripheral Nervous System; B. Central Pain Syndrome; VI. Neuropathic Pain and Management of Visceral Origin; VII. Treatment; A. Acute Pain Management; B. Chronic Neuropathic Pain Management; VIII. Future Therapeutic Modalities; A. Vanilloid Receptor 1 Antagonists; B. Serotonin and Norepinephrine Re-Uptake Inhibitor Mixed Compound; IX. Conclusion; References; Further Reading; Chapter 4 Physiology and Pharmacology: Clinical Application to Abdominal and Pelvic Visceral Pain; I. Neurophysiology Reviews [1-3]. A. Afferent and Efferent InnervationsB. Autonomic Nervous System [4]; C. Central Processing [2]; D. Peripheral Sensitization; E. Central Sensitization (Inflammation-Induced); II. Clinical Relevance of Physiology to Pharmacology; A. Dorsal Horn Targets for Analgesics [3]; B. Peripheral Sensitization Targets for Analgesics; C. Reduction/Modulation of the Transmission of Nociceptive Information; D. Epidural Site for Analgesic Administration; III. Sources of Abdominal Pain; A. Gastrointestinal System; B. Urogenital System; IV. Pelvis and Perineum [3, 5]; A. Pelvis.